Avalo Therapeutics logo

Avalo Therapeutics

AVTX | NASDAQ
Chart Builder DCF Calculator
$7.37
-$0.39 (-5.03%)
At close: Nov 16, 2026, 4:00 PM ET
$7.23
-$0.14 (-1.90%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.03%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
42.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #465/1021 (Top 46%)

Key Statistics

Market Data

Market Cap $426.16M
1D Range
7.26 7.70
52W Range
6.63 22.87

Valuation (TTM)

PE -2.55
PB 0.98
EV/EBITDA -0.36

Valuation (NTM)

Forward PE N/A
Forward PEG 0.04
Price Target $30.00
Loading financial charts...

Profile

Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical...

Sector Healthcare
Industry Biotechnology
Employees 33
IPO Date Oct 14, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$30.00
Upside
+307.06%
Buy (5)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.